RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer
Lanjing Wei, Sung Hae Kim, Ahlam M Armaly, Jeffrey Aubé, Liang Xu, Xiaoqing Wu · 2024
Read RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer by Lanjing Wei, Sung Hae Kim, Ahlam M Armaly, Jeffrey Aubé, Liang Xu, Xiaoqing Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11613925.txt.
Description
Lanjing Wei and co-authors test a drug that blocks HuR, a protein that helps cancer cells dodge death, in a 2024 study. HuR grips RNA and keeps many growth and survival messages alive in tumors. The blocker, KH-3, was tried on breast and prostate cancer cells, among others.
The drug killed cancer cells by three routes at once: the classic self-destruct path, a self-eating path, and an iron-driven path called ferroptosis. Blockers of the last two paths partly saved the cells, which proves all three were at work. The drug also shrank prostate tumors grown in mice. It works by cutting the levels of two guard proteins HuR normally protects, one for each death path. The team pitch HuR blocking as a broad anti-cancer strategy.
Catalog record
| CREATOR | Lanjing Wei, Sung Hae Kim, Ahlam M Armaly, Jeffrey Aubé, Liang Xu, Xiaoqing Wu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |